NOV 20, 2013

Advanced Genomics in Clinical and Translational Research - Fall

237 43 21731

Fall 2013 Webinar Series - November 20th

Genetic information is rapidly transforming the future of healthcare by enabling accurate and affordable diagnosis and prognosis, targeted treatments, and monitoring solutions. Life Technologies is committed to providing reliable and easy-to-use solutions, services, and support to meet the demanding needs of your work.

From scalable translational research solutions to proven clinical laboratory services and diagnostics, Life Technologies is a partner you can trust to help you efficiently develop and apply differentiated clinical applications today, and for many years into the future.

This quarterly webinar series will focus on topics in translational research and clinical diagnostics including pharmacogenomics, infectious disease, advances in cancer, inherited diseases, biomarker discovery and validation, Companion Diagnostics, reimbursement, assay validation and QC.

This event will bring together translational researchers, clinicians, laboratory professionals and experts from Life Technologies from around the world to learn about advances in advanced genomics. This conference offers an amazing opportunity as it is free to participants, and there will be no out-of-pocket expenses for travel. However, participants will still benefit from interacting with a global community of like-minded colleagues, without leaving the comfort of their office or home.

Conference participants will be able to:

  • Attend interactive live streaming video sessions
  • Have their questions answered in real-time by industry experts
  • Browse a virtual Life Technologies booth
  • Earn free CE continuing education credits


Show Resources
  • NOV 20, 2013 08:00 AM PST
    Speaker: Mark Borgman, PhD
    SEE ABSTRACT | Continuing Education: CE
  • NOV 20, 2013 09:00 AM PST
    Speaker: George A. Green IV, PhD
    SEE ABSTRACT | Continuing Education: CE
  • NOV 20, 2013 10:00 AM PST
    Speaker: Nicole Littmann
  • Sessions
  • NOV 20, 2013 08:00 AM PST
    Speaker: Mark Borgman, PhD
    SEE ABSTRACT | Continuing Education: CE
  • NOV 20, 2013 09:00 AM PST
    Speaker: George A. Green IV, PhD
    SEE ABSTRACT | Continuing Education: CE
  • NOV 20, 2013 10:00 AM PST
    Speaker: Nicole Littmann

  • Mark Borgman, PhD
    Director of Clinical Laboratory Operations at PGXL Laboratories
  • George A. Green IV, PhD
    Director, Pharmacodiagnostics, Bristol-Myers Squibb
  • Nicole Littmann
    Vice President, Client Services, Quorum Consulting
      Nicole Littmann is a leading expert in development and implementation of reimbursement strategy for innovative medical technologies, with over 15 years of experience in health care and public policy, 10 of those years in reimbursement consulting. Ms. Littmann has worked across various diagnostic and therapeutic areas, including molecular pathology, oncology, cardiology/cardiac surgery, and spine/orthopedics. From the time CMS implemented unique payment pathways for new technologies, she has been at the forefront of securing carve-out payment for her clients' technologies under Medicare. She has well-established relationships with payer decision-makers at both coverage and payment policy levels, as well in-depth technical and procedural knowledge of the AMA and CMS processes to secure CPT and HCPCS codes for these technologies. Ms. Littmann has helped manufacturers, providers, and patients navigate the health care system for access to medical innovation through clinical trial coverage and reimbursement, running efficient coding and billing hotlines, and implementing customized, effective appeals programs and patient assistance programs.
    • Dan Rhodes, PhD
      Head of Medical Science Informatics, Life Technologies
        Dr. Rhodes has a 12-year track record in cancer genomics and bioinformatics, with a significant focus on building systems to enable cutting-edge cancer research. He founded a successful cancer genomics and informatics company, Compendia Bioscience, recently acquired by Life Technologies. To build Compendia, he recruited and trained a talented team of 30 clinical scientists, bioinformaticists, cancer biologists, data curators and software engineers. As a graduate student, he led the development of Oncomine (Rhodes et al, PNAS, 2004; Rhodes et al, Nature Genetics, 2005), a cancer microarray database and data-mining application. Through the use of Oncomine, he contributed to several important discoveries, including the discovery of gene fusions in prostate cancer (Tomlins, Rhodes, et al., Science, 2005), SPINK1 in prostate cancer (Tomlins, Rhodes et al, Cancer Cell, 2008) and AGTR1 in breast cancer (Rhodes et al, PNAS, 2009). Compendia has since extensively expanded the Oncomine platform, and Oncomine is now widely recognized in academia and pharma as the leading cancer genomics data mining resource, with several hundred citations, and 15,000+ users. As Head of Medical Science Informatics at Life Technologies, he has turned his focus to next-generation sequencing data analysis, and leads several collaborations with pharmaceutical companies aimed at discovering novel oncogenic mutations and gene fusions from thousands of exomes and transcriptomes from The Cancer Genome Atlas. In his role as an Adjunct Assistant Professor at the U. of Michigan, he contributes to cancer genome analyses of prostate cancers (Grasso et al, Nature, 2012) and participates in and advises the clinical sequencing initiative MI-ONCOSEQ.
      Sponsored By

      For information on becoming a sponsor or exhibitor, please click here.

      Continuing Education (CME/CE/CEU) Credits

      The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


      To download the Program Committee brochure here.

      • Ariel Louwrier PhD

        Successful Senior Scientific Business Executive with demonstrated expertise growing markets, revenues, product pipelines and expanding technical organizations into new business opportunities. Educational and business management experience in global markets, with quantified ...

        See more See less
      • Szczepan Baran, VMD, MS

        Dr. Szczepan Baran is the Global Head, Animal Welfare and Compliance Training at Novartis Institutes for Biomedical Research. Dr. Baran received a Bachelor of Science in Pre-Veterinary Medicine from the University of Delaware, a Veterinary Medical Doctoral degree from the ...

        See more See less
      • Theral Timpson

      • Christoph H. Borchers, Ph.D.

        Dr. Borchers received his B.S., M.S. and Ph.D. from the University of Konstanz, Germany. After his post-doctoral training and employment as a staff scientist at NIEHS/NIH/RTP, NC and he was the director of the Duke - UNC Proteomics Facility and held a faculty position at UNC ...

        See more See less
      • Fred Russell Kramer, PhD

      • Hans Loyda, PhD

      • James H. Nichols, Ph.D., DABCC, FACB

      • Joely Straseski, PhD, MS, MT(ASCP), DABCC

        Dr. Straseski is a medical director of endocrinology at ARUP Laboratories and an assistant professor of pathology at the University of Utah School of Medicine. She received her PhD in pathology and laboratory medicine and a Master's degree in bacteriology from the University of ...

        See more See less
      • Josip Blonder, MD

        Dr. Blonder leads the Clinical Proteomics Group at the CRTP/FNL. FNL is a Federally Funded Research and Development Center operated by Leidos Biomedical Research, Inc., for the National Cancer Institute (NCI). In 1978, Dr. Blonder received his M.D. at the Rijeka University ...

        See more See less
      • Ottavio Arancio MD, Ph.D

        Dr. Ottavio Arancio received his Ph.D and M.D. from the University of Pisa (Italy). From 1981 to 1986 he took residency training in Neurology at the University of Verona (Italy). Dr. Arancio has held Faculty appointments at Columbia University, NYU School of Medicine and at ...

        See more See less
      • Paul LaPointe, PhD

      • Peter Blume-Jensen, MD, PhD

        Dr. Peter Blume-Jensen has extensive expertise in basic and translational cancer research, oncogenic signaling, and targeted oncology therapeutics drug discovery prior to joining Metamark as CSO in 2010.  From 2001 to 2008 Peter was department head at first Serono, US and ...

        See more See less
      • George Fritsma, MS, MT

        George Fritsma is an associate professor in Laboratory Medicine of the Department of Pathology at the University of Alabama at Birmingham. Prof. Fritsma manages, "The Fritsma Factor, Your Interactive Hemostasis Resource," a clinical coagulation ...

        See more See less
      • Eric Gluck, MD, JD

      • Amy K Saenger, PhD, DABCC, FACB

      • Andrea Rose, PhD, MBA

      • Cathy Owen

      • Sihe Wang, PhD DABCC FACB

        Dr. Sihe Wang is Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program, Cleveland Clinic, Cleveland, Ohio. He also chairs the clinical chemistry integration effort for the Cleveland Clinic Health System which ...

        See more See less
      • Sharon Geaghan, MD

        Dr. Geaghan is Chief, Pathology at Lucile Packard Children's Hospital at Stanford, and Co-Director of Clinical Laboratories at Stanford Hospital and Clinics. She also directs the Bass Pediatric Cancer Center Laboratory at the Lucile Packard Hospital; is Director of the Point of ...

        See more See less
      • Judd Moul, MD, FACS

        Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

        See more See less
      • Stephanie Willerth, PhD

        Dr. Willerth currently holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she is dually appointed in the Department of Mechanical Engineering and Division of Medical Sciences. Her research group investigates how to engineer neural tissue ...

        See more See less
      • Vincent Mauro, Ph.D.

        Dr. Mauro is an Associate Professor in the Department of Neurobiology at the Scripps Research Institute in La Jolla, California. He is also a co-founder and lead scientist of Promosome, a biotechnology company focused on bioproduction enablement and DNA vaccines. In addition, Dr ...

        See more See less
      • Pinar Bayrak-Toydemir, MD, PhD

        Dr. Bayrak-Toydemir is the medical director of the Molecular Genetics and Genomics Laboratories at ARUP and an associate professor of pathology at the University of Utah School of Medicine. Dr. Bayrak-Toydemir received her MD from the Ankara University School of Medicine in ...

        See more See less
      • Joan W Bennett, PhD

      • Charles Cantor, PhD

        Dr. Charles Cantor is a founder, and Chief Scientific Officer at SEQUENOM, Inc., which is a genetics discovery company with tools, information and strategies for determining the medical impact of genes and genetic variations. He is also the founder of SelectX Pharmaceuticals ...

        See more See less
      • Wieslaw Furmaga, MD

        Director, Clinical Chemistry Laboratory University Hospital Director, General Laboratory Cancer Treatment Research Center Director, Proteomics Laboratory UTHSC at San Antonio Interim Director, Molecular Laboratory UTHSC at San Antonio Associate Director, Mycology Laboratory UTHSC ...

        See more See less
      • Timothy Harris, PhD

        Since June 2011, Dr. Harris has served as the Senior Vice President of Translational Medicine at Biogen Idec. Dr. Harris has served as the Director of the Advanced Technology Program at SAIC Frederick since 2007 and Chief Technology Officer for SAIC Frederick since 2008. Prior to ...

        See more See less
      • Daniel Irimia, MD, PhD

      • Martin Latterich, PhD

        The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

        See more See less
      • Agnieszka Lichanzka Ph.D.

        Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

        See more See less
      • Deanne Taylor, MS, PhD

        Dr. Taylors background is in biophysics, bioinformatics, computational biology and structural biology with emphasis on human genetics and translational medicine. She obtained her Ph.D. in Biophysics from the University of Michigan, Ann Arbor, and completed a postdoctoral ...

        See more See less
      • Antonio Baines, PhD

        Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...

        See more See less
      • Cynthia Bowman MD

        Dr. Cynthia Bowman has been a broad based general pathologist for over 30 years. She graduated with a BA in Chemistry from St. Olaf College, received her MD from Vanderbilt University Medical School, and trained for 6 years at the University of California, San Francisco as a ...

        See more See less
      • R. Claudio Aguilar, Ph.D.

        Dr. Aguilar obtained his PhD degree in Immunochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. Dr. Aguilar pursued his post-doctoral training at the National institutes of Health in Bethesda, MD in the lab of the well-known cell ...

        See more See less
      • Ross J Molinaro, PhD, MT(ASCP), DABCC, FACB

        Ross J. Molinaro, PhD, MT(ASCP), DABCC, FACB is an Assistant Professor in the Department of Pathology and Laboratory Medicine at Emory University. He received his PhD in Clinical Chemistry and Molecular Medicine from Cleveland State University and completed the ComACC training ...

        See more See less
      • Mark Marzinke, PhD, BABCC

        Mark Marzinke, PhD, DABCC earned a Ph.D. in Biochemistry from the University of Wisconsin-Madison and subsequently completed a clinical chemistry fellowship at The Johns Hopkins University in 2012. During his clinical fellowship, Dr. Marzinke focused on the development and ...

        See more See less
      • Kathryn Wellen, PhD


      General LabRoots Questions

      For bugs, spam, technical support or questions please call +1-714-463-4673 or email  
      Contact us

      Virtual Events and Webinars

      Supported Configurations

      • Operating System Internet Explorer Firefox Chrome Safari
        Vista IE8+ FF10+ Chrome15+
        Windows 7 IE8+ FF10+ Chrome15+
        Windows 8 IE10 FF10+ Chrome15+
        Mac OS X   FF10+ Chrome15+ Safari5.1+
      • Cookie settings: session cookies enabled
      • Browser configuration must have JavaScript enabled
      • Adobe Flash player 10.2 or later

      To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

      Internet Connection

      • A minimum of 100Kbps is recommended for audio-only events
      • A minimum of 300Kbps is recommended for speaker on-video events

      Computer Equipment

      • Screen Resolution: Minimum 1024x768
      • Video Card: 65,000 colors minimum
      • Sound card and speakers (or headphones) for hearing webcast in full format
      • Audio Card: 16-bit minimum
      • RAM: 512MB of free RAM

      Firewall Protocol

      • HTTP on port 80 or HTTPS on port 443
      • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
      • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

      Work-At-Home Attendees

      • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

      For A Seamless Experience

      When using a mobile device, FREE Mobile Apps are available:

      - For viewing Webinars:

      - For viewing Virtual Events

      Attendee Guide

      • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

      Virtual Event and Webinar Support:

      Continuing Education (CME/CE) Support

      Loading Comments...